WE CREATE THERAPEUTIC MACROPHAGES THAT HAVE THE POTENTIAL TO CHANGE THE FUTURE IN ONCOLOGY TREATMENT

We aim to bring innovative treatment options to patients with the greatest
unmet medical need and change the way that cancer is treated

Our projects are co-financed by European Union

WELCOME TO CELLIS

Cellis is a European biotech company, with a focus in cell-based oncology therapy. We have developed a breakthrough platform technology called…>>>

TEAM

Cellis is founded on the broad and deep experience of the international team members we have brought together, providing strong expertise in scientific research, clinical development…>>>

TECHNOLOGY

Tumor microenvironment (TME) is a complex and continuously evolving structure around tumor cells consisting of innate and adaptive immune cells…>>>

PIPELINE

Cellis uses its innovative technology platform to generate a multi-product portfolio to drive the development of cutting-edge therapies to the clinics.>>>

PARTNERS

Cellis has received private and public
European financing.>>>